NO20026103L - 1-amino-alkylcycloheksaner som 5-HT3 og neuronale nikotinreseptorantagonister - Google Patents
1-amino-alkylcycloheksaner som 5-HT3 og neuronale nikotinreseptorantagonisterInfo
- Publication number
- NO20026103L NO20026103L NO20026103A NO20026103A NO20026103L NO 20026103 L NO20026103 L NO 20026103L NO 20026103 A NO20026103 A NO 20026103A NO 20026103 A NO20026103 A NO 20026103A NO 20026103 L NO20026103 L NO 20026103L
- Authority
- NO
- Norway
- Prior art keywords
- alkylcyclohexanes
- amino
- receptor antagonists
- nicotine receptor
- neuronal nicotine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
- C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59710200A | 2000-06-20 | 2000-06-20 | |
PCT/EP2001/006964 WO2001098253A2 (en) | 2000-06-20 | 2001-06-19 | 1-amino-alkylcyclohexanes as 5-ht3 and neuronal nicotinicreceptor antagonists |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20026103D0 NO20026103D0 (no) | 2002-12-19 |
NO20026103L true NO20026103L (no) | 2003-02-19 |
NO329491B1 NO329491B1 (no) | 2010-10-25 |
Family
ID=24390098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20026103A NO329491B1 (no) | 2000-06-20 | 2002-12-19 | Anvendelse av 1-aminoalkylsykloheksanforbindelser til fremstilling av medikamenter |
Country Status (21)
Country | Link |
---|---|
US (2) | US20070105961A1 (no) |
EP (2) | EP1303477A2 (no) |
JP (1) | JP4159351B2 (no) |
KR (1) | KR100570374B1 (no) |
CN (1) | CN1307147C (no) |
AR (1) | AR032756A1 (no) |
AU (2) | AU8186101A (no) |
CA (1) | CA2410852C (no) |
CZ (1) | CZ2003497A3 (no) |
EA (1) | EA006067B1 (no) |
GE (1) | GEP20053431B (no) |
HK (1) | HK1076276A1 (no) |
HU (1) | HUP0301551A3 (no) |
IL (2) | IL153480A0 (no) |
MX (1) | MXPA02012244A (no) |
NO (1) | NO329491B1 (no) |
PL (1) | PL359583A1 (no) |
TW (1) | TW593223B (no) |
UA (1) | UA74194C2 (no) |
WO (1) | WO2001098253A2 (no) |
ZA (1) | ZA200104187B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000540D0 (sv) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
TW200306189A (en) * | 2002-03-21 | 2003-11-16 | Merz Pharma Gmbh & Co Kgaa | Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
CA2502432A1 (en) * | 2002-10-24 | 2004-05-06 | Merz Pharma Gmbh & Co. Kgaa | Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
EP2260844A1 (en) | 2003-05-27 | 2010-12-15 | Merz Pharma GmbH & Co. KGaA | Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders |
CA2529674A1 (en) * | 2003-07-28 | 2005-02-03 | Merz Pharma Gmbh & Co. Kgaa | The use of 1-amino-alkylcyclohexane compounds in the treatment of pain hypersensitivity |
AR046314A1 (es) * | 2003-11-05 | 2005-11-30 | Merz Pharma Gmbh & Co Kgaa | Composiciones que comprenden ciclohexilaminas y aminoadamantanos |
TW200531680A (en) * | 2004-03-03 | 2005-10-01 | Merz Pharma Gmbh & Co Kgaa | Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease |
EP2601937A1 (en) * | 2004-06-17 | 2013-06-12 | Merz Pharma GmbH & Co. KGaA | Drinkable immediate release tablet made with direct compression of memantine or neramexane |
AU2005325292A1 (en) | 2005-01-18 | 2006-07-27 | University Of Florida | Compositions and methods for inhibiting pain |
BRPI0922057A2 (pt) | 2008-11-19 | 2015-12-15 | Envivo Pharmaceuticals Inc | tratamento dos transtorno cognitivos com (r)-7-cloro-n-(quiniclidin-3-il)benzo[b]tiofeno-2-carboxamida e sais farmeceuticamente aceitaveis do mesmo |
TWI432188B (zh) * | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類 |
WO2010069595A1 (en) | 2008-12-19 | 2010-06-24 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
UY33389A (es) | 2010-05-17 | 2011-12-30 | Mitsubishi Tanabe Pharma Corp | Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidrato |
RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9411955D0 (en) * | 1994-06-15 | 1994-08-03 | Merck Sharp & Dohme | Therapeutic agents |
US5886051A (en) * | 1995-11-08 | 1999-03-23 | University Of Florida Research Foundation, Inc. | Methods and compositions for the treatment of neurodegeneration |
ZA9610738B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
US5728728A (en) * | 1996-04-10 | 1998-03-17 | Kozachuk; Walter E. | Methods of providing neuroprotection |
US6436946B1 (en) * | 1997-05-02 | 2002-08-20 | Morris A. Mann | Xanthine-containing compositions for oral administration and uses related thereto |
US5866585A (en) * | 1997-05-22 | 1999-02-02 | Synchroneuron, Llc | Methods of treating tardive dyskinesia using NMDA receptor antagonists |
US6071966A (en) * | 1997-06-30 | 2000-06-06 | Merz + Co. Gmbh & Co. | 1-amino-alkylcyclohexane NMDA receptor antagonists |
IL133235A (en) * | 1997-06-30 | 2004-02-19 | Merz Pharma Gmbh & Co Kgaa | 1-amino-alkylcyclohexane nmda receptor antagonists and pharmaceutical compositions comprising them |
AR016212A1 (es) * | 1998-04-28 | 2001-06-20 | Astra Ab | Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas |
US6139861A (en) * | 1999-01-14 | 2000-10-31 | Friedman; Mark | Intraoral topical anti-inflammatory treatment for relief of migraine, tension-type headache, post-traumatic headache facial pain, and cervical-muscle spasm |
US6828462B2 (en) * | 2001-11-07 | 2004-12-07 | Merz Pharma Gmbh & Co. Kgaa | Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
-
2001
- 2001-05-14 TW TW090111488A patent/TW593223B/zh not_active IP Right Cessation
- 2001-05-22 ZA ZA200104187A patent/ZA200104187B/xx unknown
- 2001-06-19 KR KR1020027017329A patent/KR100570374B1/ko not_active IP Right Cessation
- 2001-06-19 JP JP2002504209A patent/JP4159351B2/ja not_active Expired - Fee Related
- 2001-06-19 GE GE5059A patent/GEP20053431B/en unknown
- 2001-06-19 EA EA200300040A patent/EA006067B1/ru not_active IP Right Cessation
- 2001-06-19 PL PL01359583A patent/PL359583A1/xx not_active Application Discontinuation
- 2001-06-19 AU AU8186101A patent/AU8186101A/xx active Pending
- 2001-06-19 HU HU0301551A patent/HUP0301551A3/hu unknown
- 2001-06-19 MX MXPA02012244A patent/MXPA02012244A/es active IP Right Grant
- 2001-06-19 AU AU2001281861A patent/AU2001281861B2/en not_active Ceased
- 2001-06-19 EP EP01960342A patent/EP1303477A2/en not_active Withdrawn
- 2001-06-19 UA UA2003010457A patent/UA74194C2/uk unknown
- 2001-06-19 CZ CZ2003497A patent/CZ2003497A3/cs unknown
- 2001-06-19 AR ARP010102918A patent/AR032756A1/es unknown
- 2001-06-19 EP EP10184507A patent/EP2277850A1/en not_active Withdrawn
- 2001-06-19 CA CA002410852A patent/CA2410852C/en not_active Expired - Fee Related
- 2001-06-19 WO PCT/EP2001/006964 patent/WO2001098253A2/en active IP Right Grant
- 2001-06-19 IL IL15348001A patent/IL153480A0/xx active IP Right Grant
- 2001-06-19 CN CNB01811413XA patent/CN1307147C/zh not_active Expired - Fee Related
-
2002
- 2002-12-16 IL IL153480A patent/IL153480A/en not_active IP Right Cessation
- 2002-12-19 NO NO20026103A patent/NO329491B1/no not_active IP Right Cessation
-
2005
- 2005-09-22 HK HK05108300A patent/HK1076276A1/xx not_active IP Right Cessation
-
2006
- 2006-12-21 US US11/643,129 patent/US20070105961A1/en not_active Abandoned
-
2010
- 2010-07-26 US US12/804,610 patent/US20100298442A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ZA200104187B (en) | 2002-11-22 |
EA006067B1 (ru) | 2005-08-25 |
EP1303477A2 (en) | 2003-04-23 |
HK1076276A1 (en) | 2006-01-13 |
HUP0301551A3 (en) | 2005-04-28 |
CN1307147C (zh) | 2007-03-28 |
GEP20053431B (en) | 2005-01-25 |
JP2004501130A (ja) | 2004-01-15 |
CN1620419A (zh) | 2005-05-25 |
HUP0301551A2 (hu) | 2003-11-28 |
CA2410852A1 (en) | 2001-12-27 |
TW593223B (en) | 2004-06-21 |
IL153480A0 (en) | 2003-07-06 |
WO2001098253A2 (en) | 2001-12-27 |
KR100570374B1 (ko) | 2006-04-24 |
JP4159351B2 (ja) | 2008-10-01 |
UA74194C2 (uk) | 2005-11-15 |
AR032756A1 (es) | 2003-11-26 |
EP2277850A1 (en) | 2011-01-26 |
PL359583A1 (en) | 2004-08-23 |
NO20026103D0 (no) | 2002-12-19 |
CZ2003497A3 (cs) | 2004-08-18 |
EA200300040A1 (ru) | 2003-06-26 |
US20100298442A1 (en) | 2010-11-25 |
AU8186101A (en) | 2002-01-02 |
MXPA02012244A (es) | 2004-09-06 |
IL153480A (en) | 2007-08-19 |
WO2001098253A3 (en) | 2002-04-25 |
AU2001281861B2 (en) | 2006-08-17 |
US20070105961A1 (en) | 2007-05-10 |
CA2410852C (en) | 2007-04-24 |
KR20030053475A (ko) | 2003-06-28 |
NO329491B1 (no) | 2010-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20043064L (no) | 1-alkyl-1-azoniabisyklo [2.2.2] oktankarbamatderivater og anvendelse av disse som muskarine reseptorantagonister | |
NO20032797L (no) | Substituerte pyridoindoler som serotonin agonister og antagonister | |
NO20023216D0 (no) | Instrumentert sementeringsplugg og system for samme | |
NO20030471D0 (no) | Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor | |
IS7216A (is) | Bensamíð og heteróarýlamíð sem P2X7 viðtaka mótlyf | |
NO20040072L (no) | Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme | |
NO20013809D0 (no) | Indolderivater og anvendelse derav som MCP-1 antagonister | |
IS7041A (is) | 5-HT viðtakabindlar og notkun þeirra | |
NO20040028L (no) | Substituerte anilinske piperidiner som MCH-selektive antagonister | |
NO20052739D0 (no) | CCR5-antagonister som medikamenter | |
NO20023728D0 (no) | Manipuleringsresistente, orale opioidagonistformuleringer | |
ATE318259T1 (de) | Selektive neurokinin-antagonisten | |
NO20023485D0 (no) | 1,3-disubstituerte pyrrolidiner som alfa-2- adrenoceptorantagonister | |
HK1076276A1 (en) | 1-Amin-alkylcyclohexanes as 5-ht3 and neuronal nicotinicreceptor antagonists | |
DK1440059T3 (da) | 3-azabicyclo(3.1.0)hexanderivater som opioidreceptorantagonister | |
NO20004668D0 (no) | 1-(3-heteroarylpropyl- eller -prop-2-enyl)-4- benzylpiperidiner anvendt som NMDA-reseptorantagonister | |
NO990243D0 (no) | Trovafloxacin-mesylat-tablett | |
NO20025762D0 (no) | Bicykliske cykloheksylaminer og anvendelse derav som NMDA- reseptorantagonister | |
ATE469875T1 (de) | Nk1-antagonisten | |
ATE374183T1 (de) | Nk1-antagonisten | |
DE29903029U1 (de) | Nagel | |
NO20004144D0 (no) | Heterocykliske forbindelser, deres fremstilling og anvendelse som takykinin reseptor antagonister | |
ATE370114T1 (de) | Zwitterionische tachykinin-rezeptor-antagonisten | |
DK1296961T3 (da) | 1,4-diazepan-2,5-dionderivater og anvendelse deraf som NK-1-receptorantagonister | |
DE60140529D1 (de) | Feuerlöschende Zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |